Abstract
Abstract
Purpose of Review
To review the role of ocular surface epithelial (corneal and conjunctival) ion transporters in the pathogenesis and treatment of dry eye disease (DED).
Recent Findings
Currently, anti-inflammatory agents are the mainstay of DED treatment, though there are several agents in development that target ion transport proteins on the ocular surface, acting by pro-secretory or anti-absorptive mechanisms to increase the tear fluid film volume. Activation or inhibition of selected ion transporters can alter tear fluid osmolality, driving water transport onto the ocular surface via osmosis. Several ion transporters have been proposed as potential therapeutic targets for DED, including the cystic fibrosis transmembrane conductance regulator (CFTR), calcium-activated chloride channels (CaCCs), and the epithelial sodium channel (ENaC).
Summary
Ocular surface epithelial cell ion transporters are promising targets for pro-secretory and anti-absorptive therapies of DED.
Publisher
Springer Science and Business Media LLC
Reference93 articles.
1. Zhao M, Chalmers L, Cao L, Vieira AC, Mannis M, Reid B. Electrical signaling in control of ocular cell behaviors. Prog Retin Eye Res. 2012;31(1):65–88.
2. Devor DC, Hamilton KL. Ion channels and transporters of epithelia in health and disease. New York, Imprint: Springer; 2016.
3. Shteinberg M, Haq IJ, Polineni D, Davies JC. Cystic fibrosis. Lancet. 2021;397(10290):2195–211.
4. Mrugacz M, Minorowska A, Bakunowicz-Lazarczyk A, Zywalewska N. Dry eye syndrome in children with cystic fibrosis. Med Wieku Rozwoj. 2004;8(4 Pt 1):865–70.
5. Cil O, Phuan PW, Gillespie AM, Lee S, Tradtrantip L, Yin J, et al. Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins. FASEB J. 2017;31(2):751–60.